Suggestions
Cheryl Zimberlin
Early-stage Healthcare Investor
Cheryl Zimberlin is the Executive Director at Liago Bio, a biotechnology company focused on innovative solutions in the life sciences sector. She has a strong background in the biotech industry and has been recognized for her leadership and contributions to the field.
Professional Background
- Current Role: Executive Director at Liago Bio, where she oversees strategic initiatives and drives the company's vision in biotechnological advancements.
- Previous Experience: Cheryl has held various leadership positions, including a role at Calypso Biotech and serving on the board of Rewind Therapeutics, showcasing her extensive experience in managing biotech ventures.
Achievements
- Emerging Leaders 2023: She was recognized as one of the Emerging Leaders in 2023, highlighting her impact and potential in the biotechnology landscape.3
- Active Participation: Cheryl is involved in numerous industry events and discussions, reflecting her commitment to advancing biobusiness and fostering innovation.12
Cheryl Zimberlin's career demonstrates a blend of strategic leadership and a commitment to advancing biotechnology, making her a notable figure in her field.
Highlights
Apr 12 · FinSMEs
ImmuneBridge Raises $12M in Seed Funding - FinSMEs
Apr 11 · Business Wire
ImmuneBridge Raises $12M from M Ventures and Insight Partners ... - Business Wire